John McGrath, EVP & Chief Financial Officer at Atara Biotherapeutics, Inc. (ATRA), sold 37,000 shares at $22.32 ($901K) on 2018-01-12, disclosed to the SEC on 2018-01-12.
Open-market sale of $901k ATRA by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.77 | 3,500 | $73K | 8.1% |
| 2 | $22.32 | 3,500 | $78K | 8.7% |
| 3 | $25.00 | 30,000 | $750K | 83.3% |
| Total | $24.35 avg | 37,000 | $901K | 100% |
| Filing → |
| ATRA | SELL | 2018-01-02 | $640K | — | Filing → |
| ATRA | SELL | 2017-08-17 | $60K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $60K | — | Filing → |